New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch

💊 As cannabis dispensaries continue to expand in New Jersey and across the country, clinicians should recognize that increased retail availability may correlate with rising patient use and exposure, particularly among populations with chronic pain, anxiety, and sleep disorders who might view cannabis as an alternative to conventional treatments. While local business expansion reflects changing legal and regulatory landscapes, the clinical relevance lies in understanding that greater accessibility does not necessarily mean improved clinical outcomes or safety profiles for our patients. Providers should remain aware that despite legalization, evidence for cannabis efficacy remains mixed for most indications, quality and potency vary considerably between products, and potential harms including cannabis use disorder, cognitive effects, and drug interactions persist regardless of dispensary proximity. The practical implication is that clinicians should proactively screen patients about cannabis use during routine visits, counsel on evidence-based alternatives for their presenting conditions, and maintain current knowledge about local availability to have informed conversations about risks and benefits in their specific community context